Thyroid Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
If you have already had your whole thyroid removed (Group 1):
- You are aged 16 or older
- You have been diagnosed with papillary thyroid cancer (PTC) where the tumour was between 1cm and 4cm, regardless of genetic markers found in the tumour
- Your surgeon was able to remove all visible cancer during the operation
- The cancer had not spread to lymph nodes, or had only spread to a small number of nearby lymph nodes (5 or fewer) with no spread beyond the lymph node itself
- The cancer was either fully contained within the thyroid or had only just started to grow slightly beyond it
- The cancer does not show certain higher-risk patterns under the microscope (small amounts may be acceptable — confirm with trial site)
- There is no sign the cancer has grown into blood vessels (small microscopic involvement of tiny vessels may still be acceptable — confirm with trial site)
- You have a specific type called encapsulated follicular variant PTC, where the cancer has only broken through its surrounding capsule
- You have a very small papillary thyroid cancer (1cm or less) that is either found in multiple spots, or has spread to a small number of nearby lymph nodes (5 or fewer, with no spread beyond the lymph node)
- You have been diagnosed with follicular thyroid cancer (including oncocytic or Hürthle cell type), where the tumour was between 1cm and 4cm, regardless of genetic markers
- Your follicular thyroid cancer is the minimally invasive type, with capsule involvement and/or a small amount of blood vessel involvement (4 or fewer spots), and is contained within or just beyond the thyroid
If you have not yet had thyroid surgery (Group 2):
- You are aged 16 or older
- A biopsy or needle test has shown a low-risk differentiated thyroid cancer
- The tumour appears to be between 1cm and 4cm based on scans, regardless of genetic markers
- There is no sign the cancer has spread to nearby lymph nodes
- The other side of your thyroid does not have any suspicious nodules, or any nodules found there have been assessed and appear non-concerning
Who may not be able to join:
If you have already had your whole thyroid removed (Group 1):
- Your tumour was larger than 4cm
- You have a single very small tumour (1cm or less) with no lymph node involvement
- You have been diagnosed with NIFTP (a borderline condition that is not considered true cancer)
- You have anaplastic, poorly differentiated, or medullary thyroid cancer
- There was cancer left behind that the surgeon could visibly see after the operation
- The cancer had grown extensively outside the thyroid gland
- The cancer is classified as stage T4, or has visibly invaded surrounding tissues or structures
- Cancer spread to nearby lymph nodes involved more than 5 lymph node spots, or had spread beyond the lymph node itself
- Cancer has spread to lymph nodes further away from the thyroid
- The cancer has spread to other parts of the body (for example, lungs or bones)
- Your papillary thyroid cancer shows any of these higher-risk features: widely invasive growth, poorly differentiated cells, anaplastic cells, or is mainly made up of higher-risk cell types (such as tall cell, columnar cell, hobnail, or diffuse sclerosing)
- Your follicular thyroid cancer (including oncocytic or Hürthle cell type) shows any of these features: extensive blood vessel invasion (more than 4 spots), widely invasive growth, poorly differentiated cells, or anaplastic cells
If you have not yet had thyroid surgery (Group 2):
- The cancer has already spread to other parts of the body (for example, lungs or bones)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Dae Kim, The Royal Marsden Hospital
Phone: 020 3108 4875
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
3 Year Recurrence Rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.